As of May 2024 Atara Biotherapeutics has a market cap of $81.7 Million. This makes Atara Biotherapeutics the world's 7518th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $81.7 M | 56.32% |
2023 | $52.26 M | -83.21% |
2022 | $0.31 B | -78.46% |
2021 | $1.44 B | -11.72% |
2020 | $1.63 B | 74.93% |
2019 | $0.93 B | -41.39% |
2018 | $1.59 B | 188.26% |
2017 | $0.55 B | 35.13% |
2016 | $0.40 B | -45.47% |
2015 | $0.75 B | 42.68% |
2014 | $0.52 B |
On May 1st, 2024 the market cap of Atara Biotherapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ImmunoGen
IMGN | $8.72 B | 10,578.20% | ๐บ๐ธ USA |
Agenus
AGEN | $0.27 B | 240.74% | ๐บ๐ธ USA |
Affimed
AFMD | $81.16 M | -0.66% | ๐ฉ๐ช Germany |